PETMED EXPRESS INC (PETS) 18.95 +0.09 (+0.48%)
18.95 +0.09 (+0.48%)
US7163821066 - Common Stock - After market: 18.95 0 (0%)
Fundamental Rating
We assign a fundamental rating of 6 out of 10 to PETS. PETS was compared to 85 industry peers in the Internet & Direct Marketing Retail industry. While PETS has a great health rating, its profitability is only average at the moment. PETS has a expensive valuation and it also scores bad on growth
Profitability
Profitability Rating
PETS's Return On Assets of 9.26% is amongst the best returns of the industry. PETS outperforms 92% of its industry peers. The industry average Return On Assets is -10.01%.
PETS has a Profit Margin of 5.98%. This is amongst the best returns in the industry. The industry average is -9.55%. PETS outperforms 91% of its industry peers.
PETS has a Return On Equity of 11.35%. This is comparable to the industry average of 11.35%.
The Piotroski-F score of PETS is 5.00. This is a neutral score and indicates average health and profitability for PETS.
VS Industry
ROA (9.26%) VS Industry: 92% outperformed.
-510.15
22.89
ROE (11.35%) VS Industry: 52% outperformed.
0.22
110.84
Profit Margin (5.98%) VS Industry: 91% outperformed.
-520.03
30.44
Valuation
Valuation Rating
The Price/Earnings Ratio is 24.29, which indicates a rather expensive current valuation of PETS.
With a Forward Price/Earnings Ratio of 16.89, PETS is valued correctly.
With a price book ratio of 2.89, PETS is valued correctly.
PETS's Price/Earning Ratio is slightly more expensive than the industry average, which is at 13.38.
Compared to an average industry price book ratio of 1.81, PETS is valued more expensive than its industry peers.
When comparing the Enterprise Value to EBITDA ratio of PETS to the average industry ratio of 10.74, PETS is valued more expensive than its industry peers.
VS Industry
Price/Earnings (24.29) VS Industry: 39% outperformed.
159.61
1.07
Price/Book (2.89) VS Industry: 36% outperformed.
151.13
0.13
Enterprise Value/ EBITDA (14.43) VS Industry: 36% outperformed.
3,220.61
0.21
Growth
Growth Rating
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
PETS shows a decrease in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -2.34% yearly.
Based on estimates for the next 5 years, PETS will show a small growth in Earnings Per Share. The EPS will grow by 0.77% on average per year.
The Revenue has decreased by -7.73% in the past year.
PETS shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 1.87% yearly.
PETS is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 0.81% yearly.
The earnings per share for PETS have decreased strongly by -39.53% in the last year.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | -2.34% | -16.27% | -39.53% | -13.43% | 1.93% | -1.72% | 0.77% |
| Revenue | 1.87% | -1.19% | -7.73% | -2.57% | 1.34% | 1.34% | 0.81% |
Health
Health Rating
PETS has a Current Ratio of 4.52. This indicates that PETS is financially healthy and has no problem in meeting its short term obligations.
The Current Ratio of PETS is much better than the industry average of 1.77. PETS has a better rating than 95% of its industry peers.
PETS has a Quick Ratio of 3.41. This indicates that PETS is financially healthy and has no problem in meeting its short term obligations.
The Quick Ratio of PETS is much better than the industry average of 1.11. PETS has a better rating than 93% of its industry peers.
With a Debt to Equity ratio of 0.00, PETS is doing better than the averages in the industry. The industry average is at 0.16.
An Altman-Z score of 11.59 indicates that PETS is not in any danger for bankruptcy at the moment.
PETS has one of the better Altman-Z scores in its industry. It is much better than the industry average of 1.58. PETS has a better score than 100% of its industry peers.
PETS has a Piotroski-F score of 5.00. This indicates an average health and profitability for PETS.
VS Industry
Debt/Equity (0) VS Industry: 65% outperformed.
38.00
0.00
Quick Ratio (3.41) VS Industry: 93% outperformed.
0.04
9.90
Current Ratio (4.52) VS Industry: 95% outperformed.
0.11
9.90
Altman-Z (11.59) VS Industry: 100% outperformed.
-34.75
11.59
Dividend
Dividend Rating
PETS has a Yearly Dividend Yield of 6.04%, which is a nice return.
PETS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
PETS has paid a dividend for at least 10 years, which is a reliable track record.
Compared to an average industry Dividend Yield of 6.04, PETS has a dividend in line with its industry peers.
The dividend of PETS has a limited annual growth rate of 4.22%.
PETS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
155.84% of the earnings are spent on dividend by PETS. This is not a sustainable payout ratio.
VS Industry
Dividend Yield (6.04%) VS Industry: 50% outperformed.
1.95
22.87
PETMED EXPRESS INC18.95
NASDAQ:PETS (12/8/2022, 3:05:45 PM)+0.09 (+0.48%)
| GICS Sector | Consumer Discretionary | ||
| GICS IndustryGroup | Retailing | ||
| GICS Industry | Internet & Direct Marketing Retail | ||
| Earnings (Last) | N/A N/A | Earnings (Next) | 01-23 2023-01-23/amc |
| Ins Owners | 0.98% | Inst Owners | 78.23% |
| Market Cap | 399.38M | Analysts | 50 |
| PE | 24.29 | Fwd PE | 16.89 |
| PEG (NY) | N/A | PEG (5Y) | N/A |
| P/S | 1.52 | P/B | 2.89 |
| EV/EBITDA | 14.43 | ||
| Dividend Yield | 6.04% | Dividend Growth | 4.22% |
| DP | 155.84% | Ex-Date | 11-17 2022-11-17 (0.3) |
| EPS 1Y | -39.53% | EPS 3Y | -16.27% |
| EPS 5Y | -2.34% | EPS growth Q2Q | -58.06% |
| EPS Next Y | -13.43% | EPS Next 2Y | 1.93% |
| EPS Next 3Y | -1.72% | EPS Next 5Y | 0.77% |
| Revenue growth 1Y | -7.73% | Revenue growth 3Y | -1.19% |
| Revenue growth 5Y | 1.87% | Revenue growth Q2Q | -2.96% |
| Revenue Next Year | -2.57% | Revenue Next 2Y | 1.34% |
| Revenue Next 3Y | 1.34% | Revenue Next 5Y | 0.81% |
| Current Ratio | 4.52 | Quick Ratio | 3.41 |
| Altman-Z | 11.59 | F-Score | 5 |
| Debt/Equity | 0 | WACC | 9.96% |
| ROIC/WACC | 4.03 | ||
| ROA | 9.26% | ROE | 11.35% |
| ROICexgc | 40.09% | ROIC | 10.49% |
| PM | 5.98% | OM | 7.11% |
| Asset Turnover | 1.55 | ||
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA